NEX 1285Alternative Names: NEX1285
Latest Information Update: 26 Apr 2007
At a glance
- Originator Nextran
- Mechanism of Action Immunosuppressants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Xenotransplant rejection
Most Recent Events
- 26 Apr 2007 No development reported - Preclinical for Xenotransplant rejection in USA (unspecified route)
- 17 Oct 2003 Preclinical trials in Xenotransplant rejection in USA (unspecified route)